"The radio craze will die out in time."
Thomas Edison ; 1922
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8168797 | Oxazolidinone derivative with difluorophenyl moiety, pharmaceutically acceptable salt thereof, preparation method thereof and antibiotic composition containing the same as an active ingredient Novel oxazolidinone derivatives with a difluorophenyl moiety, represented by Chemical Formula 1, pharmaceutically acceptable salts thereof, a preparation method thereof, and a pharmaceutical composition containing the same as an active ingredient are provided. Exhib... | 05/01/2012 |
| 7999115 | Spiro antibiotic derivatives The invention relates to compounds of formula (I) wherein R1 represents H, alkyl, alkoxy, cyano or halogen; one of U and X represents CH or N and the other represents CH, or, in the case of U, may also represent CRa and, in the case of X, may a... | 08/16/2011 |
| 7763734 | Synthesis, structure and use of bisoxazolidines for asymmetric catalysis and synthesis One aspect of the invention relates to chiral bisoxazolidines and their use in asymmetric catalysis. The chiral bisoxazolidines are a novel class of compounds that is expected to find multiple applications, for example, in asymmetric synthesis. For example, a bisoxa... | 07/27/2010 |
| 7514567 | Oxazolidinone nicotinic acetylcholine receptor agonists Compounds of formula I: and pharmaceutically-acceptable salts thereof, wherein Q, Ar1, A and Ar2 are as defined in the specification, pharmaceutical compositions and formulations containing them, metho... | 04/07/2009 |
| 7402548 | Benzoxazole compounds, process for producing the same and herbicides The present invention relates to benzoxazole compounds represented by the following formula (I): wherein R1 to R4 may be the same or different from each other, and each represe... | 07/22/2008 |
| 7371807 | Blocked biuretized isocyanates The present invention is directed to blocked biuret group-containing polyisocyanate compositions, wherein the blocking agent is of the formula: wherein R1, R2, R3 and R4 may be th... | 05/13/2008 |
| 7354946 | Biarylurea derivatives The present invention relates to a compound of Formula (I) and the manufacturing method(s) thereof and the use thereof: Formula (I) wherein: Ar is a nitrogen-containing heteroaromatic ring group; X and Z are each a c... | 04/08/2008 |
| 7332500 | Heterocyclic antiviral compounds This invention relates to piperidine derivatives of formulae Ia and Ib with substituents as defined herein useful in the treatment of a variety of disorders, including those in which the modulation of CCR5 receptors is implicated. More particularly, the present inve... | 02/19/2008 |
| 7268135 | Biaryl sulfonamides and methods for using same The present invention relates to biaryl sulfonamides and their use as, for example, metalloproteinase inhibitors. ... | 09/11/2007 |
| 7202251 | Bicyclic anilide spirohydantoin CGRP receptor antagonists The present invention is directed to compounds of the formula: that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache... | 04/10/2007 |
| 7199125 | Spiro-cyclic compounds useful as anti-inflammatory agents The present invention is directed to compounds having the formula (I): useful in treating inflammatory and immune diseases, in which K and L are independently, O or S; Q is —C(═O)— or optionally substituted... | 04/03/2007 |
| 7153971 | Compounds containing oxazolidinone moiety and uses thereof A compound and method for producing an enantiomerically enriched epoxide from an olefin using a chiral ketone and an oxidizing agent is disclosed. In particular, the compound is of the formula: I wherein R1, R2, R3 and R4 ... | 12/26/2006 |
| 7126005 | Process for preparing florfenicol The present invention is directed to a new process of preparing highly pure Florfenicol. The invention is further directed to new oxazolidine derivatives useful in making Florfenicol and processes of making these derivatives. Examples of such intermediates include (... | 10/24/2006 |
| 7087676 | Blocked polyisocyanates Blocked polyisocyanates and one-component stoving systems containing these blocked polyisocyanates, and the preparation thereof and their use for the preparation of lacquers, paints, adhesives and elastomers, wherein blocked polyisocyanates are prepared by reacting ... | 08/08/2006 |
| 7074852 | Blocked polyisocyanates Blocked polyisocyanates and one-component stoving systems containing these blocked polyisocyanates, and the preparation thereof and their use for the preparation of lacquers, paints, adhesives and elastomers. The blocked polyisocyanates are derived from polyisocyana... | 07/11/2006 |
| 6822094 | Spiro compounds and their use Spiro compounds of the formula (I), in which at least one of the radicals K1, L, M, N1, R1, R2, R3, R4 is one of the following groups ... | 11/23/2004 |
| 6777410 | Isoindole derivatives This invention relates to compounds represented by the general formula [I] wherein, R represents an azido group, etc., R1 and R2 are the same or different and represent hydrogen atoms, etc., R3 ... | 08/17/2004 |
| 6683709 | Photochromic pyran compounds Photochromic pyran compounds and their use in synthetic resin objects of all types, especially for ophthalmic applications, particularly spiro compounds having a fluorene structure derived from naphthopyrans, which are known as spirofluorenopyrans. By int... | 01/27/2004 |
| 6670507 | Process for the preparation of aryloctanoyl amides Compounds of formula I ##STR1## wherein R1 is for example 3-methoxyprop-3-yloxy, R2 is for example methoxy, R3 and R4 are in each case for example isopropyl, and R5 is H2 NC(O)--[C(CH | 12/30/2003 |
| 6586452 | C1 to C4 side chain modified nodulisporic acid analogs The present invention relates to novel nodulosporic acid derivatives, which are acaricidal, antiparasitic, insecticidal and anthelmintic agents.... | 07/01/2003 |
| 6528534 | Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation This invention relates to certain spirocyclic compounds substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.... | 03/04/2003 |
| 6512112 | Aminoaryl oxazolidinone N-oxides The present invention provides for aminoaryl oxazolidinone N-oxide compounds of Formula I ##STR1## wherein the variables are as defined herein. These compounds are exceedingly water soluble which is useful in preparing pharmaceutical formulations of ... | 01/28/2003 |
| 6444819 | Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands Disclosed are compounds of the formula: ##STR1## or pharmaceutically acceptable addition salts thereof wherein: Y represents oxygen or sulfur; Z is nitrogen or CH; R1, R2 and R3 independently represent organic or inorganic subs... | 09/03/2002 |
| 6444825 | Process for the preparation of an oxazolidinecarboxylic acid which is useful for preparing therapeutically active taxoids A method for preparing an oxazolidinecarboxylic acid of general formula (I), which is useful for preparing therapeutically active taxoids of general formula (III), from an oxazolidinecarboxylic acid of general formula (II). In formulae (I), (II) and (III)... | 09/03/2002 |
| 6437145 | Method of producing oxazolidinones, the use thereof and oxazolidinones The invention concerns a method of producing oxazolidinones of formula (I), wherein R1 -R5 have the meanings given in the description, by reacting cyclical anhydrides of formula (II) with carbonyl compounds of general formula (III) a... | 08/20/2002 |
| 6387892 | Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI Novel compounds having the Formulas 1 through 8, wherein the symbols have the meaning defined in the specification, and certain previously known compounds have been discovered to act as inhibitors of the cytochrome P450RAI (retinoic acid inducible) enzyme... | 05/14/2002 |
| 6369271 | Process for preparing derivatives of biphenyl-2-carboxylic acid The invention relates to a process for large-scale industrial production of biphenyl-2-carboxylic acid derivatives (I) ##STR1## wherein R1 and R2 may have the meanings given in the specification and claims.... | 04/09/2002 |
| 6365747 | Method for the preparation of citalopram The present invention relates to a method for the preparation of citalopram or any of its enantiomers and acid addition salts thereof comprising treatment of a compound of formula (IV), wherein X is O or S; R1 -R2 are each independen... | 04/02/2002 |
| 6340751 | Process for the preparation of 4-substituted azetidinone derivatives Disclosed is a process for the preparation of a 4-substituted azetidinone derivative, which comprises reacting an azetidinone derivative and an amide compound in the presence of a magnesium compound such as those represented by the following formulas (II)... | 01/22/2002 |
| 6277985 | Aminoaryl oxazolidinone N-oxides The present invention provides for aminoaryl oxazolidinone N-oxide compounds of Formula I ##STR1## wherein the variables are as defined herein. These compounds are exceedingly water soluble which is useful in preparing pharmaceutical formulations of ... | 08/21/2001 |
| 6271387 | Process for producing 1,3-oxazolidine derivatives A process produces 1,3-oxazolidine derivatives by reacting an imine derivative of the following formula (1): ##STR1## with an epoxy compound of the following formula (2): ##STR2## to yield an oxazolidine derivative of the following formula (3): ##STR... | 08/07/2001 |
| 6194582 | Taxoids, their preparation and pharmaceutical compositions containing them New taxoids of general formula (I), their preparation, and pharmaceutical compounds containing them. ##STR1## In general formula (I), for example, Ar represents an aryl radical, R represents an alkoxyacetyl radical, R1 represents a benzoyl radical o... | 02/27/2001 |
| 6107036 | Heterocyclic dioxethane substrates, process for their preparation and their use Compounds of the general formula Ia and Ib are described ##STR1## in which R1 and R2 are the same or different and represent hydrogen, straight-chain or branched C1 to C6 lower alkyl or an aryl group option... | 08/22/2000 |
| 6020491 | Monomeric and polymeric cyclic amine and N-halamine compounds Cyclic amine monomers and polymers and N-halamine biocidal polymer compounds are provided. Representative monomers have the structure: ##STR1## wherein R1 is selected from the group consisting of hydrogen and from C1 to C4 | 02/01/2000 |
| 6015823 | 4-Cyclohexylphenyl-oxazolines and their use for controlling animal pests The present invention relates to novel 4-cyclohexylphenyl-oxazolines of the formula (I) ##STR1## in which X1, X2, X3, R1 and R2 are each as defined in the description, to processes for their prep... | 01/18/2000 |
| 5962683 | Oxazoline compounds as stabilizers A description is given of compounds of the formula I ##STR1## where r is 0 or 1 and y is a number from the range 1-3; X is a direct bond or --NR8 --, --CO--, --CONH-- or --COO-- or a divalent aliphatic or mixed aromatic-aliphatic C1 | 10/05/1999 |
| 5902814 | Spiro-Azabicyclic Compounds useful in therapy There are provided new compounds of formula I: ##STR1## wherein R represents hydrogen or methyl; and n represents 1 or 2; or a pharmaceutically acceptable acid addition salt thereof, together with processes for preparing them, compositions containing them... | 05/11/1999 |
| 5869680 | Process for preparing taxane derivatives This invention relates to a method of preparing taxane derivatives of general formula (I) by esterification of protected baccatine III or 10-deacetylbaccatine III by means of an acid of general formula (VII), elimination of protection groupings of the est... | 02/09/1999 |
| 5864041 | Process for producing threo-3-(3,4-dihydroxyphenyl)serine Racemic or optically active threo-3-(3,4-dihydroxyphenyl)serine can be readily produced via a few short steps by a process involving the steps of reacting a racemic or optically active N-acyl DOPA derivative represented by the formula I!: ##STR1## ... | 01/26/1999 |
| 5840217 | Spiro compounds and their use as electroluminescence materials Use of spiro compounds of the formula (I) ##STR1## where K1 and K2 are, independently of one another, conjugated systems, in electroluminescence devices. Preferred compounds of the formula (I) are 9,9'-spirobifluorene derivatives ... | 11/24/1998 |